• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • New England Institute for Neurology and Headache, Stamford, CT

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 6 - 9 of 9

  • Page:
  • 1
  • 2

Rimegepant for the Acute and Preventive Treatment of Migraine in Women: Results From 4 Randomized, Placebo-Controlled Clinical Trials

Author:Hutchinson, Susan   Pavlovic, Jelena   Ailani, Jessica   Mullin, Kathleen   Croop, Robert   Thiry, Alexandra   Morris, Beth   Kamen, Lisa   Abbott, Chandra   

Session Name:P9: Headache: The Gepant Pipeline  

Topic:Headache  

Program Number:P9.007  

Author Institution:Orange County Migraine & Headache Center, Irvine, CA  Albert Einstein College of Medicine, Bronx, NY  Medstar Georgetown Neurology, McLean, VA  New England Institute for Neurology and Headache, Stamford, CT  Biohaven Pharmaceuticals, Wynnewood, PA  Biohaven Pharmaceuticals, New Haven, CT  Biohaven Pharmaceuticals, Inc., New Haven, CT  

  • View Abstract
  • View Disclosure

Long-Term Safety and Tolerability of Zavegepant 10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a 1-Year Open-label Safety Trial

Author:Berman, Gary   Mullin, Kathleen   Pavlovic, Jelena   Smith, Timothy   Croop, Robert   Madonia, Jennifer   Mosher, Linda   Hould, Jennifer   Lipton, Richard   

Session Name:P10: Headache: Towards Precision Medicine 1  

Topic:Headache  

Program Number:P10.009  

Author Institution:Clinical Research Institute , Minneapolis, MN  New England Institute for Neurology and Headache, Stamford, CT  Albert Einstein College of Medicine, Bronx, NY  StudyMetrix Research, Saint Louis, MO  Biohaven Pharmaceuticals, Wynnewood, PA  Biohaven Pharmaceuticals, New Haven, CT  Biohaven Pharmaceuticals, Wallingford, CT  

  • View Abstract
  • View Disclosure

Medication Preference, Satisfaction, and Clinical Improvement Among Adults Receiving Long-Term Treatment With Rimegepant for Migraine

Author:Mullin, Kathleen   Pavlovic, Jelena   Hutchinson, Susan   Lipton, Richard   Jensen, Christopher   Thiry, Alexandra   Kamen, Lisa   Croop, Robert   

Session Name:P10: Headache: Towards Precision Medicine 1  

Topic:Headache  

Program Number:P10.011  

Author Institution:New England Institute for Neurology and Headache, Stamford, CT  Albert Einstein College of Medicine, Bronx, NY  Orange County Migraine & Headache Center, Irvine, CA  Biohaven Pharmaceuticals, New Haven, CT  Biohaven Pharmaceuticals, Wynnewood, PA  

  • View Abstract
  • View Disclosure

Long-term Safety of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia in Phase 3, Open-label, Multicenter ASPEN-OLS Trial

Author:McAllister, Peter   Jinnah, H.   Evidente, Virgilio Gerald   Patel, Atul   Gross, Todd   Rubio, Roman   Vitarella, Domenico   

Session Name:P11: Movement Disorders: Dystonia 1  

Topic:Movement Disorders  

Program Number:P11.003  

Author Institution:New England Institute for Neurology and Headache, Stamford, CT  Emory University, Atlanta, GA  Movement Disorders Center of Arizona, Scottsdale, AZ  Kansas City Bone & Joint Clinic, Overland Park, KS  Revance Therapeutics, Inc., Nashville, TN  Blue Obsidian Consulting, LLC, Redwood City, CA  

  • View Abstract
  • View Disclosure

Displaying 6 - 9 of 9

  • Page:
  • 1
  • 2

© 2015 Mira Smart Conference | http://www.mirasmart.com